Radiomics - research challenges identified by EURAMED

Size: px
Start display at page:

Download "Radiomics - research challenges identified by EURAMED"

Transcription

1 Radiomics - research challenges identified by EURAMED Prof. Christoph Hoeschen EURAMED Past-President, member of ExB, head of scientific committee

2 Vision To lead the European research activities in medical radiation protection and to assume an umbrella function for the harmonisation of practice to advance the European radiation protection safety culture in medicine. Mission To jointly improve medical care through sustainable research efforts in medical radiation protection To serve as a platform for medical radiation protection research, linking researchers and clinicians, adopting a harmonized approach to lobbying at European level to impact the European research funding landscape To develop an aligned approaches and responses to European research calls 2

3 Procedure to determine gaps Based on EURAMED SRA Also use Joint Roadmap draft, individual EURAMED roadmap, priority statements Analyse former and current projects regarding their results and/or proposed research Not exclusively 3

4 EURAMED Preliminary Gap Analysis: Short list of identified gaps 4

5 EURAMED Preliminary Gap Analysis: Short list of identified gaps 5

6 EURAMED Preliminary Gap Analysis: Short list of identified gaps 6

7 GAP 1 Fixed activity approach versus individualized dosimetry-based activity determination in radionuclide therapy Fixed activity approach: prescriptions in radionuclide therapy are based on a fixed amount of activity for all patients Individualized dosimetry approach in radionuclide therapy: treatment optimization by anticipating required activity to be administered to an individual patient 7

8 GAP 1 Fixed activity approach versus individualized dosimetry-based activity determination in radionuclide therapy For all medical exposure of patients for radiotherapeutic purposes, exposures of target volumes shall be individually planned and their delivery appropriately verified taking into account that doses to nontarget volumes and tissues shall be as low as reasonably achievable and consistent with the intended radiotherapeutic purpose of the exposure. EU directive 2013/59/EURATOM Article 56 Radiotherapeutic means pertaining to radiotherapy, including nuclear medicine for therapeutic purposes EU directive 2013/59/EURATOM Article 4 (Definitions) 8

9 GAP 1 Fixed activity approach versus individualized dosimetry-based activity determination in radionuclide therapy 9

10 GAP 2 Artificial intelligence in medical radiation protection Artificial intelligence, machine learning and deep learning can support medical radiation protection (dose estimation, dose management, image quality assessment and especially dose reduction). Translating approaches into clinical practice, determine drawbacks and limitations, evaluate systems are essential aspects of such approaches and are missing still 10

11 Artificial intelligence in medical radiation protection Development of dose and imaging biobanks for benchmarking, establishment of DRLs and research can help considerably in dose optimization from medical exposures. 11

12 GAP 2a Artificial intelligence in medical radiation protection Radiomics: a tool to extract quantitative information out of the images. Several software packages provide radiomic features from medical images using data-characterization algorithms. These features have the potential to uncover disease characteristics. Radiomics could be used together with texture analysis approaches to look for effects related to individual sensitivity of single organs. 12

13 Radiomics slides based on those of Ralph Leijenaar Disclosure Ralph Leijenaar Co-inventor of patents related to Radiomics Chief Technology Officer of the company OncoRadiomics Employed by pttheragnostic

14 Radiomics Radiomics first published by MAASTRO in 2012 Lambin P, et al. Eur J Cancer 2012;48:

15 Radiomics hypothesis The Radiomic hypothesis One can extract more quantitative information from standard imaging in contrast with RECIST, WHO ) Radiology: Implicit knowledge Interpretability QUANTIFICATION [Lambin P, et al. Eur J Cancer 2012;48: ] RADIOMICS Extract large amount of quantitative features from images 15

16 Radiomics - workflow The Radiomics workflow in a nutshell Imaging feature extraction modelling A high-throughput approach to convert medical images to minable data The analysis extracts diagnostic, theragnostic, prognostic and predictive Radiomics signatures 16

17 Radiomic features 1. Tumor image intensity 2. Shape 3. Texture 4. (multi-scale) filtering

18 Image acquisition & reconstruction [Mackin D, et al. Invest Radiol 2015;50: ] For all inserts: 1. Calculate normalized feature values 2. Hierarchical clustering

19 Radiomics: great potential Imaging is non-invasive Imaging is routinely and repeatedly performed in radiation oncology Radiomics utilizes the full 3D information of the tumor (in contrast to biopsies) Multiple imaging modalities even more information CT PET(CT) MR Novel: combined PET/MR, dual energy CT

20 Radiomics - animated 20

21 Radiomics ideas for radiation protection Use radiomics to develop markers to easily stratify patients for individualized therapies, interventions and also imaging procedures applying doses in the mid dose range Easy to transfer into clinical practice Verify radiation biology results in patients Improve radiation epidemiology based on patient cohorts due to improved inclusion or exclusion criteria and or feasibility to build sub-groups based on individual radiation sensitivity or susceptibility 21

22 GAP 3 Radiation protection approaches in medical applications based on individual radiosensitivity In many cases, patients are exposed to radiation in a region which is already affected by a disease. This might be correlated with higher or lower sensitivity to ionizing radiation of the exposed organs. It is important to develop methods for medical exposures in diagnostic, minimally invasive or radiotherapeutic procedures based on ionizing radiation to avoid side effects and adverse events by prediction of individual radiosensitivity and develop strategies for adjusting doses correspondingly Research should focus on medical applications. 22

23 GAP 3a Effects of low and high ionizing radiation doses on immune system There is quite some evidence to suggest that high-dose irradiation correlates with immunosuppression, while low-dose irradiation correlates with immunostimulation, at least for quite a number of patients. Animal and patient studies are needed to define radiation dose levels that will promote or suppress the development of an antigen specific and/or antigen non-specific immune response. It could e.g. be investigated on how far such mechanisms are depending on individual patient status or whether they are correlated with individual radiosensitivity. Advanced dosimetric methods should accurately estimate radiation dose to each specific tissue/organ of the body. 23

24 Radiomics entering a new fascinating world of (medical) radiation protection! Thank you for your attention! 24

Quantitative Radiomics System Decoding the Tumor Phenotype. John Quackenbush and Hugo Aerts

Quantitative Radiomics System Decoding the Tumor Phenotype. John Quackenbush and Hugo Aerts Quantitative Radiomics System Decoding the Tumor Phenotype John Quackenbush and Hugo Aerts The Radiomics Hypothesis The tumor s structural phenotype reflects its molecular and clinical properties. This

More information

Strategic Research Agenda of EURAMED, highlighting synergies

Strategic Research Agenda of EURAMED, highlighting synergies Strategic Research Agenda of EURAMED, highlighting synergies Christoph Hoeschen Otto-von-Guericke University Magdeburg on behalf of the steering committee The Strategic Research Agenda Common Strategic

More information

MELODI statement 2018 Gap analysis

MELODI statement 2018 Gap analysis MELODI statement 2018 Gap analysis MELODI (Multidisciplinary European Low Dose Initiative) is a European Platform dedicated to low dose ionizing radiation risk research. The purpose of the MELODI Association

More information

8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET

8/10/2016. PET/CT Radiomics for Tumor. Anatomic Tumor Response Assessment in CT or MRI. Metabolic Tumor Response Assessment in FDG-PET PET/CT Radiomics for Tumor Response Evaluation August 1, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu Anatomic Tumor Response Assessment

More information

Common strategic research agenda for radiation protection in medicine

Common strategic research agenda for radiation protection in medicine Insights Imaging (2017) 8:183 197 DOI 10.1007/s13244-016-0538-x STATEMENT Common strategic research agenda for radiation protection in medicine European Association of Nuclear Medicine (EANM) 1 European

More information

Quantitative Radiomics System: Decoding the Tumor Phenotype

Quantitative Radiomics System: Decoding the Tumor Phenotype HARVARD MEDICAL SCHOOL Quantitative Radiomics System: Decoding the Tumor Phenotype Hugo Aerts Director, Computational Imaging and Bioinformatics Lab (CIBL) Dana-Farber Cancer Institute, Brigham and Women

More information

Radiomics: a new era for tumour management?

Radiomics: a new era for tumour management? Radiomics: a new era for tumour management? Irène Buvat Unité Imagerie Moléculaire In Vivo (IMIV) CEA Service Hospitalier Frédéric Joliot Orsay, France irene.buvat@u-psud.fr http://www.guillemet.org/irene

More information

Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view.

Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Yolande Lievens, MD, PhD Chair Radiation Oncology Department, Ghent University Hospital Co-Chair HERO

More information

THE GUSTAVE ROUSSY / INSERM PLATFORM

THE GUSTAVE ROUSSY / INSERM PLATFORM Retrospective dose reconstruction in external beam radiotherapy for use in epidemiology: THE GUSTAVE ROUSSY / INSERM PLATFORM Dimitri Lefkopoulos PhD, Medical Physics Medical physics Department Gustave

More information

BORDET DEPARTMENT RADIATION ONCOLOGY

BORDET DEPARTMENT RADIATION ONCOLOGY BORDET DEPARTMENT RADIATION ONCOLOGY The Radiation Oncology Department has been providing patients with high quality, tailored radiation oncology care for the last 60 years in a multidisciplinary setting

More information

Project Fiche IPA Horizontal Programme on Nuclear Safety and Radiation Protection

Project Fiche IPA Horizontal Programme on Nuclear Safety and Radiation Protection 1. Basic information Project Fiche - 2009 IPA Horizontal Programme on Nuclear Safety and Radiation Protection 1.1 CRIS Number: 2009/021-640 1.2 Title: Upgrading of Radiation Protection and Safety Monitoring

More information

19 CP Add teaching file export related codes

19 CP Add teaching file export related codes 19 CP-1680 - Add teaching file export related codes Page 1 1 Status Final Text 2 Date of Last Update 2017/09/14 3 Person Assigned David Clunie 4 mailto:dclunie@dclunie.com 5 Submitter Name David Clunie

More information

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy PET/CT for Tumor Response Evaluation August 4, 2016 Wei Lu, PhD Department of Medical Physics www.mskcc.org Department of Radiation Oncology www.umaryland.edu FDG PET/CT for Cancer Imaging Staging and

More information

IAEA Support to Medical Physics in Africa and Latin America: achievements & challenges

IAEA Support to Medical Physics in Africa and Latin America: achievements & challenges IAEA Support to Medical Physics in Africa and Latin America: achievements & challenges Ahmed Meghzifene Head, Dosimetry & Medical Radiation Physics Presentation objectives To learn about: 1. IAEA activities

More information

Integrated Research Application System (IRAS)

Integrated Research Application System (IRAS) Integrated Research Application System (IRAS) Question specific guidance Part B Section 3 Exposure to ionising radiation The following document collates all guidance for the questions in Part B: Section

More information

19 CP Add teaching file export related codes

19 CP Add teaching file export related codes 19 CP-1680 - Add teaching file export related codes Page 1 1 Status Letter Ballot 2 Date of Last Update 2017/06/21 3 Person Assigned David Clunie 4 mailto:dclunie@dclunie.com 5 Submitter Name David Clunie

More information

POSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION

POSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION POSITION DESCRIPTION Position Title: Location: Research Coordinator Clinical Trials National Secretariat, Brisbane-based Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) Reporting Relationships:

More information

PROGRAMME OVERVIEW Saturday, October 13, 2018

PROGRAMME OVERVIEW Saturday, October 13, 2018 Saturday, October 13, 2018 Plenary Hall Meeting Room 26 Hall 1 Hall 2 Hall 3 Hall X Hall Y Hall 28 - - - - - - - - - - Advisory Council Meeting Delegates Assembly 1 Radiopharmacy/ Drug Development Trial

More information

IAEA experiences with QUATRO audits. J.Izewska, J. Zubizarreta Division of Human Health International Atomic Energy Agency

IAEA experiences with QUATRO audits. J.Izewska, J. Zubizarreta Division of Human Health International Atomic Energy Agency IAEA experiences with QUATRO audits J.Izewska, J. Zubizarreta Division of Human Health International Atomic Energy Agency Introduction of comprehensive audit The IAEA has recognized the need to audit medical

More information

Challenges and Opportunities for In Vivo Imaging in Oncology

Challenges and Opportunities for In Vivo Imaging in Oncology Challenges and Opportunities for In Vivo Imaging in Oncology Daniel C. Sullivan, M.D. Unraveling of the genome and proteome, and advances in biomedical technology are changing the practice of medicine

More information

SunCHECK Patient Comprehensive Patient QA

SunCHECK Patient Comprehensive Patient QA The SunCHECK Platform SunCHECK Patient Comprehensive Patient QA SunCHECK Patient // Comprehensive Patient QA Automate Your Patient QA SunCHECK Patient automates all your Patient QA needs from Secondary

More information

Radiation Protection Research. From FP6 to FP7. Neale Kelly

Radiation Protection Research. From FP6 to FP7. Neale Kelly Radiation Protection Research From FP6 to FP7 Neale Kelly Risks at low and protracted doses Topic % Radiobiology 46 Epidemiology 25 Medical uses 7 Risk and emergency management Other topics Radioecology

More information

Precision of pre-sirt predictive dosimetry

Precision of pre-sirt predictive dosimetry International Course on THERANOSTICS AND MOLECULAR RADIOTHERAPY Precision of pre-sirt predictive dosimetry Hugo Levillain Department of Nuclear Medicine Medical Physics Jules Bordet Institute, Université

More information

Regions Hospital Delineation of Privileges Radiation Oncology

Regions Hospital Delineation of Privileges Radiation Oncology Regions Hospital Delineation of Privileges Radiation Oncology Applicant s Last First M. Instructions: Place a check-mark where indicated for each core group you are requesting. Review education and basic

More information

JHM-IRB Guidelines for Radiation Statements

JHM-IRB Guidelines for Radiation Statements JHM-IRB Guidelines for Radiation Statements When a participant in a research study is subjected to ionizing radiation exposure (other than that which is incidental for the standard medical management of

More information

8/1/2018. Radiomics Certificate, AAPM Radiomics Certificate, AAPM Introduction to Radiomics

8/1/2018. Radiomics Certificate, AAPM Radiomics Certificate, AAPM Introduction to Radiomics Radiomics Certificate, AAPM 2018 Directors Ahmed Hosny, Hugo Aerts, Dana-Farber Cancer Center Laurence Court, University of Texas MD Anderson Cancer Center Faculty Xenia Fave, University of California

More information

iviewdose Confidence and assurance in dose delivery

iviewdose Confidence and assurance in dose delivery iviewdose Confidence and assurance in dose delivery As radiotherapy techniques advance and treatment plans become more complex, involving escalated doses and increasingly conformal deliveries, the need

More information

Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets

Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets Statistical Considerations for Novel Trial Designs: Biomarkers, Umbrellas and Baskets Bibhas Chakraborty, PhD Centre for Quantitative Medicine, Duke-NUS March 29, 2015 Personalized or Precision Medicine

More information

nuclear science and technology

nuclear science and technology EUROPEAN COMMISSION nuclear science and technology Gene-radiation interactions: their influence on pre-menopausal breast cancer risk after Chernobyl (GENE-RAD-INTERACT) Contract N o FIGH-CT2002-00215 Final

More information

Children and radiation in medicine protecting the young patients

Children and radiation in medicine protecting the young patients Children and radiation in medicine protecting the young patients European scenario and actions needed R. Fotter IAEA General Conference, September 2011 Dep. of Radiology Div. of Pediatric Radiology Main

More information

Radiomics for outcome modeling: state-of-the-art and challenges

Radiomics for outcome modeling: state-of-the-art and challenges Workshop Avancées récentes en analyse d images médicales multi-modales Radiomics for outcome modeling: state-of-the-art and challenges Mathieu Hatt, PhD, HDR CR INSERM mathieu.hatt@inserm.fr Laboratoire

More information

Mike Becich, MD PhD Distinguished University Professor and Chair, Department of Biomedical Informatics University of Pittsburgh School of Medicine

Mike Becich, MD PhD Distinguished University Professor and Chair, Department of Biomedical Informatics University of Pittsburgh School of Medicine Affiliated with the University of Pittsburgh School of Medicine Mike Becich, MD PhD Distinguished University Professor and Chair, Department of Biomedical Informatics University of Pittsburgh School of

More information

CaPTk: Cancer Imaging Phenomics Toolkit

CaPTk: Cancer Imaging Phenomics Toolkit CaPTk: Cancer Imaging Phenomics Toolkit Interaction Personalized Diagnostics CaPTk Quantitative Imaging Phenomic Features Radiogenomics Image Analysis Machine Learning What is CaPTk? A dynamically growing

More information

Continuing the momentum to deliver improved performance. Robert Cascella Chief Business Leader Diagnosis & Treatment

Continuing the momentum to deliver improved performance. Robert Cascella Chief Business Leader Diagnosis & Treatment Continuing the momentum to deliver improved performance Robert Cascella Chief Business Leader Diagnosis & Treatment Key takeaways Diagnosis & Treatment strategy is aligned with the Quadruple Aim Gaining

More information

Strategic Research Agenda of EURADOS, highlighting synergies

Strategic Research Agenda of EURADOS, highlighting synergies Strategic Research Agenda of EURADOS, EURADOS WORKING GROUP 12 highlighting synergies Željka Knežević Ruđer Bošković Institute On behalf of EURADOS Workshop on synergies of SRA of EURAMED, MELODI and EURADOS,

More information

HEALTHCARE AI DEVELOPMENT CYCLE

HEALTHCARE AI DEVELOPMENT CYCLE Dr. Keith Dreyer Chief Science Officer, ACR Data Science Institute ACR Board of Chancellors, Chairman Informatics Commission Chief Data Science Officer, MGH, BWH, Partners Healthcare Associate Professor

More information

Herlev radiation oncology team explains what MRI can bring

Herlev radiation oncology team explains what MRI can bring Publication for the Philips MRI Community Issue 46 2012/2 Herlev radiation oncology team explains what MRI can bring The radiotherapy unit at Herlev University Hospital investigates use of MRI for radiotherapy

More information

Arbiter of high-quality cancer care

Arbiter of high-quality cancer care Arbiter of high-quality cancer care Developer and Promoter of National Programs to facilitate the fulfillment of member institution missions in education, research, and patient care and to incrementally

More information

Horizon Scanning Technology Briefing National Helical Tomotherapy Horizon Hi-ART System for Scanning external cancer Centre radiotherapy August 2006

Horizon Scanning Technology Briefing National Helical Tomotherapy Horizon Hi-ART System for Scanning external cancer Centre radiotherapy August 2006 Horizon Scanning Technology Briefing National Horizon Scanning Centre Helical Tomotherapy Hi-ART System for external cancer radiotherapy August 2006 This technology briefing is based on information available

More information

Wednesday 12 September Advanced imaging science to practice 14:30 14:55. Recent advances in computed tomography (CT) technology

Wednesday 12 September Advanced imaging science to practice 14:30 14:55. Recent advances in computed tomography (CT) technology 14:30 14:55 Recent advances in computed tomography (CT) technology Dr Gareth Iball, Leeds Teaching Hospitals NHS Trust All modern CT systems incorporate iterative reconstruction (IR) techniques. Their

More information

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research

More information

A Snapshot on Nuclear Cardiac Imaging

A Snapshot on Nuclear Cardiac Imaging Editorial A Snapshot on Nuclear Cardiac Imaging Khalil, M. Department of Physics, Faculty of Science, Helwan University. There is no doubt that nuclear medicine scanning devices are essential tool in the

More information

Advancing treatment of cancer through imaging technologies Hans Hofstraat

Advancing treatment of cancer through imaging technologies Hans Hofstraat Advancing treatment of cancer through imaging technologies Hans Hofstraat Philips Research November 7, 2016 1 Providing better oncology care Your needs for better ways to locate cancers earlier, aiming

More information

Current and Planned Reports and Conferences of the National Council on Radiation Protection and Measurements

Current and Planned Reports and Conferences of the National Council on Radiation Protection and Measurements Current and Planned Reports and Conferences of the National Council on Radiation Protection and Measurements Thomas S. Tenforde President Presentation to Nuclear and Radiation Studies Board National Academy

More information

Does the lung nodule look aggressive enough to warrant a more extensive operation?

Does the lung nodule look aggressive enough to warrant a more extensive operation? Accepted Manuscript Does the lung nodule look aggressive enough to warrant a more extensive operation? Michael Kuan-Yew Hsin, MBChB, MA, FRCS(CTh), David Chi-Leung Lam, MD, PhD, FRCP (Edin, Glasg & Lond)

More information

Background Information

Background Information Background Information Erlangen, November 26, 2017 RSNA 2017 in Chicago: South Building, Hall A, Booth 1937 Artificial intelligence: Transforming data into knowledge for better care Inspired by neural

More information

Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy

Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy VERSION 2.1 April 2015 Table of Contents Abbreviations & Glossary... 3 Executive Summary...

More information

Dose Estimates for Nuclear Medicine Procedures: What are they? Where do they come from?

Dose Estimates for Nuclear Medicine Procedures: What are they? Where do they come from? Dose Estimates for Nuclear Medicine Procedures: What are they? Where do they come from? SNM Continuing Education Lecture Salt Lake City, UT -- June 6, 2010 Darrell R. Fisher Pacific Northwest National

More information

Radiation Assurance Research Exposure Form

Radiation Assurance Research Exposure Form Radiation Assurance Research Exposure Form F1: To be completed by the applicant This section is to be completed by the applicant before submission of the application for Radiation Assurance. The HRA will

More information

Clinical Precision for Best Cancer Care. Dee Mathieson Senior Vice President Oncology Business Line Management

Clinical Precision for Best Cancer Care. Dee Mathieson Senior Vice President Oncology Business Line Management Clinical Precision for Best Cancer Care Dee Mathieson Senior Vice President Oncology Business Line Management Optimizing clinical results Key drivers in modern Radiation Therapy Clinical precision Continuous

More information

Small field dosimetry, an example of what a Medical Physicist does (& some more examples) A/PROF SCOTT CROWE MEDICAL PHYSICIST

Small field dosimetry, an example of what a Medical Physicist does (& some more examples) A/PROF SCOTT CROWE MEDICAL PHYSICIST Small field dosimetry, an example of what a Medical Physicist does (& some more examples) A/PROF SCOTT CROWE MEDICAL PHYSICIST What is a Medical Physicist? Medical physics application of physics concepts

More information

8/1/2017. Imaging and Molecular Biomarkers of Lung Cancer Prognosis. Disclosures. The Era of Precision Oncology

8/1/2017. Imaging and Molecular Biomarkers of Lung Cancer Prognosis. Disclosures. The Era of Precision Oncology Imaging and Molecular Biomarkers of Lung Cancer Prognosis Ruijiang Li, PhD Assistant Professor of Radiation Oncology 08/01/2017 Stanford University Department of Radiation Oncology School of Medicine Disclosures

More information

Watson Summit Prague 2017

Watson Summit Prague 2017 Watson for Oncology Matěj Adam Watson Health Executive May 2017 Watson Summit Prague 2017 an IBM Company Leadership & 23 Years Patent Leadership Research Spend Global Presence Technology 7300+ 2015 $6B

More information

Brochure More information from

Brochure More information from Brochure More information from http://www.researchandmarkets.com/reports/2375238/ Breast Imaging Technologies Market (Digital Mammography,3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular

More information

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer

Utility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department

More information

PET in Radiation Therapy. Outline. Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy. 1. Tumor segmentation in PET

PET in Radiation Therapy. Outline. Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy. 1. Tumor segmentation in PET Tumor Segmentation in PET and in Multimodality Images for Radiation Therapy Wei Lu, Ph.D. Department of Radiation Oncology Mallinckrodt Institute of Radiology Washington University in St. Louis Outline

More information

Strategic Research Agenda of the Multidisciplinary European Low Dose Initiative (MELODI) 2017

Strategic Research Agenda of the Multidisciplinary European Low Dose Initiative (MELODI) 2017 Strategic Research Agenda of the Multidisciplinary European Low Dose Initiative (MELODI) 2017 M. Kreuzer, A. Auvinen, S. Bouffler, E. Cardis, M. Durante, J.R. Jourdain, M. Harms-Ringdahl, B. Madaz, R.

More information

Applying Tissue Phenomics to Colorectal Clinical Questions

Applying Tissue Phenomics to Colorectal Clinical Questions Applying Tissue Phenomics to Colorectal Clinical Questions International Symposium for Tissue Phenomics San Francisco October 2014 Peter Caie Senior Research Fellow University of St Andrews Systems Pathology

More information

Appendix I. List of stakeholders consulted with on the Patient Radiation Protection Manual and members of the Medical Exposure Radiation Unit

Appendix I. List of stakeholders consulted with on the Patient Radiation Protection Manual and members of the Medical Exposure Radiation Unit References References The accuracy, quality and relevance of these works are not guaranteed or uniform and more recent information may have superseded these works. This list is not exhaustive. It does

More information

Application of the Commission's Recommendations for the Protection of People in

Application of the Commission's Recommendations for the Protection of People in ICRP Publication 127 ICRP Publication 126 ICRP Publication 125 ICRP Publication 124 ICRP Publication 123 ICRP Publication 122 ICRP Publication 121 ICRP Publication 120 ICRP 2011 Proceedings Radiological

More information

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320 Quality ID #147: Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS

More information

Author(s) : Title: HERCA WG Medical Applications / Sub WG Exposure of Asymptomatic Individuals in Health Care

Author(s) : Title: HERCA WG Medical Applications / Sub WG Exposure of Asymptomatic Individuals in Health Care Author(s) : Juergen Griebel, (Bfs, DE) Steve Ebdon-Jackson (HPA, UK) Title: HERCA WG Medical Applications / Sub WG Exposure of Asymptomatic Individuals in Health Care Position Paper on Screening Summary:

More information

Introduction to European DoReMi programme on low dose risk

Introduction to European DoReMi programme on low dose risk Introduction to European DoReMi programme on low dose risk Prof. Sisko Salomaa DoReMi Coordinator STUK - Radiation and Nuclear Safety Authority, Finland ICRR2015, Kyoto, Japan Aim of DoReMi to promote

More information

Session 83X Dose Management: Patient and Staff Radiation Safety in Radiology

Session 83X Dose Management: Patient and Staff Radiation Safety in Radiology Prepared for the Foundation of the American College of Healthcare Executives Session 83X Dose Management: Patient and Staff Radiation Safety in Radiology Presented by: Bert Van Meurs Christoph Wald, MD

More information

Targeting and Treating Cancer

Targeting and Treating Cancer Targeting and Treating Cancer Mark R. Baker, Chief Executive Officer Jefferies 2016 DISCLOSURE NOTICE This presentation may contain projections and other forward-looking statements regarding future events.

More information

Improving personal dosimetry of medical staff wearing radioprotective garments: Design of a new whole-body dosimeter using Monte Carlo simulations

Improving personal dosimetry of medical staff wearing radioprotective garments: Design of a new whole-body dosimeter using Monte Carlo simulations Improving personal dosimetry of medical staff wearing radioprotective garments: Design of a new whole-body dosimeter using Monte Carlo simulations Clarita Saldarriaga Vargas, Corinne Amalberto, Lara Struelens,

More information

NCRP Overview Program Area Committee 4 Radiation Protection in Medicine

NCRP Overview Program Area Committee 4 Radiation Protection in Medicine NCRP Overview Program Area Committee 4 Radiation Protection in Medicine Jerrold T. Bushberg Ph.D., DABMP Scientific Vice-President National Council on Radiation Protection and Measurements Bethesda, Maryland

More information

What Radiologists do?

What Radiologists do? Multimodality Imaging in Oncology 2018 March 5 th 9th Diagnostic Imaging in Oncology What Radiologists do? Chikako Suzuki, MD, PhD Department of Diagnostic Radiology, KS Solna Department of Molecular Medicine

More information

Predicting Maximum Pacemaker/ICD Dose in SAVI HDR Brachytherapy

Predicting Maximum Pacemaker/ICD Dose in SAVI HDR Brachytherapy Predicting Maximum Pacemaker/ICD Dose in SAVI HDR Brachytherapy Chaitanya Kalavagunta Ph.D. University of Maryland School of Medicine, Baltimore, Maryland. Background Aging population - Number of patients

More information

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION Proton Therapy Edition 2016 PROTON THERAPY WORLD MARKET REPORT & DIRECTORY EDITION 2016 A report written by Paul-Emmanuel Goethals & Richard Zimmermann Page 1/7 www.medraysintell.com Proton Therapy Edition

More information

A. DeWerd. Michael Kissick. Larry. Editors. The Phantoms of Medical. and Health Physics. Devices for Research and Development.

A. DeWerd. Michael Kissick. Larry. Editors. The Phantoms of Medical. and Health Physics. Devices for Research and Development. Larry Editors A. DeWerd Michael Kissick The Phantoms of Medical and Health Physics Devices for Research and Development ^ Springer Contents 1 Introduction to Phantoms of Medical and Health Physics 1 1.1

More information

1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán

1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán Risk in Dosimetry. Industry Stand point 1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán Agenda IBA. IBA Dosimetry Risks in Dosimetry Product development Product manufacturing Product

More information

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017 NCCIH s New Approach to Funding Clinical Trials Informational Webinar April 18, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H., Branch Chief, Clinical Research in Complementary and Integrative Health

More information

EURADOS European radiation Dosimetry group Activities in Environmental Monitoring

EURADOS European radiation Dosimetry group Activities in Environmental Monitoring EURADOS European radiation Dosimetry group Activities in Environmental Monitoring Tero Karhunen, STUK CORES Symposium 6.9.2018, Tampere, Finland European Radiation Dosimetry Group EURADOS is a network

More information

Artificial Intelligence in Breast Imaging

Artificial Intelligence in Breast Imaging Artificial Intelligence in Breast Imaging Manisha Bahl, MD, MPH Director of Breast Imaging Fellowship Program, Massachusetts General Hospital Assistant Professor of Radiology, Harvard Medical School Outline

More information

Jefferies Healthcare Conference

Jefferies Healthcare Conference Jefferies Healthcare Conference Jean-Marc BOTHY - CSO June 8, 2017 2017 IBA SA Disclaimer This presentation may contain forward-looking statements concerning industry outlook, including growth drivers;

More information

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. YY Translated English of Chinese Standard: YY

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. YY Translated English of Chinese Standard: YY Translated English of Chinese Standard: YY0831-2011 www.chinesestandard.net Email: Sales@ChineseStandard.net ICS 11.040.50 YY C 43 PHARMACEUTICAL INDUSTRY STANDARD OF THE PEOPLE S REPUBLIC OF CHINA YY

More information

London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare. Professor Reza Razavi Centre Director

London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare. Professor Reza Razavi Centre Director London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare Professor Reza Razavi Centre Director The traditional healthcare business model is changing Fee-for-service Fee-for-outcome

More information

PLEASE TURN OFF YOUR CELL PHONES

PLEASE TURN OFF YOUR CELL PHONES CAP Companion Meeting at 2017 USCAP Mission Control The Value of Cancer Protocols, Staging Manuals, and Key Revisions to Select Tumor Sites Sub-topic Title> PLEASE TURN OFF YOUR CELL PHONES Moderators:

More information

Noninvasive Detection of Coronary Artery Disease Using Resting Phase Signals and Advanced Machine Learning

Noninvasive Detection of Coronary Artery Disease Using Resting Phase Signals and Advanced Machine Learning Noninvasive Detection of Coronary Artery Disease Using Resting Phase Signals and Advanced Machine Learning Thomas D. Stuckey, MD FACC, FSCAI Medical Director/Section Chief LeBauer-Brodie Center for Cardiovascular

More information

QA for Clinical Dosimetry with Emphasis on Clinical Trials

QA for Clinical Dosimetry with Emphasis on Clinical Trials QA for Clinical Dosimetry with Emphasis on Clinical Trials Geoffrey S. Ibbott, Ph.D. and RPC Staff G. Ibbott, AAPM Summer School, June 24, 2009 1 QA Infrastructure for Clinical Trials Participating Institutions

More information

SNMMI House of Delegates Bi-Annual Report Computer and Instrumentation Council Goals 2017 Mid-Winter Meeting

SNMMI House of Delegates Bi-Annual Report Computer and Instrumentation Council Goals 2017 Mid-Winter Meeting SNMMI House of Delegates Bi-Annual Report Computer and Instrumentation Council Goals 2017 Mid-Winter Meeting Overview: SNMMI Councils and Centers provide professional networking and educational programs

More information

Radiation Protection education of Radiology trainees

Radiation Protection education of Radiology trainees Radiation Protection education of Radiology trainees A' Radiology Department- Aretaieion Hospital- National & Kapodistrian University of Athens M. Lyra,, C. Armpilia,, C. Antypas and A.Gouliamos The aim

More information

DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS

DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS Andrius IVANAUSKAS*, Eduardas ALEKNAVIČIUS*, Arvydas BURNECKIS*, Albert MILLER *Institute of Oncology Vilnius

More information

Activity report from JCOG physics group

Activity report from JCOG physics group 2013.5.9 Global Harmonization Group meeting ICCR2013 @ Melbourne Activity report from JCOG physics group 1 Hokkaido University, Graduate School of Medicine, 2 National Cancer Center, Center for Cancer

More information

IAEA activities in Medical Physics

IAEA activities in Medical Physics IAEA activities in Medical Physics Giorgia Loreti Training Officer (Medical Physics) G.Loreti@iaea.org IAEA - International Atomic Energy Agency Department of Nuclear Sciences and Applications Division

More information

The MetroHealth System. Creating the HIT Organizational Culture at MetroHealth. Creating the HIT Organizational Culture

The MetroHealth System. Creating the HIT Organizational Culture at MetroHealth. Creating the HIT Organizational Culture CASE STUDY CASE STUDY The MetroHealth System Optimizing Health Information Technology to Increase Vaccination Rates The MetroHealth System in Cleveland, Ohio, was the first safety-net health care system

More information

Instructions for Completing the UVMCC Clinical Research Protocol Submission Form UVMCC CLINICAL RESEARCH PROTOCOL SUBMISSION FORM

Instructions for Completing the UVMCC Clinical Research Protocol Submission Form UVMCC CLINICAL RESEARCH PROTOCOL SUBMISSION FORM Instructions for Completing the UVMCC Clinical Research Protocol Submission Form SUBMITTING THE APPLICATION 1. The PI must complete this application. National Clinical Trials Network (NCTN) Protocols only

More information

Radiomics: Extracting more information from medical images using advanced feature analysis

Radiomics: Extracting more information from medical images using advanced feature analysis European Journal of Cancer (2012) 48, 441 446 Available at www.sciencedirect.com journal homepage: www.ejconline.com Radiomics: Extracting more information from medical images using advanced feature analysis

More information

PRECISION MEDICINE: THE FUTURE OF PRIMARY CARE

PRECISION MEDICINE: THE FUTURE OF PRIMARY CARE PRECISION MEDICINE: THE FUTURE OF PRIMARY CARE? FRANZ RISCHARD, D.O., M.SC. ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF ARIZONA DIVISION OF PULMONARY AND CRITICAL CARE MEDICINE DIVISION OF TRANSLATIONAL

More information

Imaging Systems. Gene Saragnese EVP and GM Imaging Systems

Imaging Systems. Gene Saragnese EVP and GM Imaging Systems Imaging Systems Gene Saragnese EVP and GM Imaging Systems 1 Imaging Systems Strategy Drive Customer & Patient Experience Quality, reliability and service delivery Ease of use, speed, comfort, dose Deliver

More information

Chapter 10. Summary, conclusions and future perspectives

Chapter 10. Summary, conclusions and future perspectives Chapter 10 Summary, conclusions and future perspectives 10.1 SUMMARY In this thesis, a new tumor imaging tracer in nuclear medicine is studied. This 123 tracer, L-3-[ I]Iodo-alpha-methyl-tyrosine (IMT),

More information

nuclear science and technology

nuclear science and technology EUROPEAN COMMISSION nuclear science and technology Identification and isolation of susceptibility genes involved in radiation-induced cancer in humans (SUS GENES IN RAD CAR) Contract N o FIGH-CT1999-00002

More information

Liquid Biopsies. Next Generation Cancer Molecular Diagnostics

Liquid Biopsies. Next Generation Cancer Molecular Diagnostics Liquid Biopsies Next Generation Cancer Molecular Diagnostics Forward Looking Statements 2 Statements pertaining to future financial and/or operating results, future research, diagnostic tests and technology

More information

Novel techniques for normal tissue toxicity modelling. Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy

Novel techniques for normal tissue toxicity modelling. Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy Novel techniques for normal tissue toxicity modelling Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy Disclosure: I have no conflict of interest An honorarium is

More information

Patient Safety in the Age of Big Data

Patient Safety in the Age of Big Data CIRMS 2018 Patient Safety in the Age of Big Data Machine Learning, Measurements, and Standards for Making Radiation Treatments Safer Christopher Berlind, PhD Co-founder and Chief Technology Officer, Oncora

More information

Introducing A New Platform In Cancer Care Robotically Assisted Sonic Therapy (RAST)

Introducing A New Platform In Cancer Care Robotically Assisted Sonic Therapy (RAST) Introducing A New Platform In Cancer Care Robotically Assisted Sonic Therapy (RAST) CED Life Science Conference February 27, 2018 Almost 40% of us will be diagnosed with cancer at some point in our lives

More information

Clinical Trial Credentialing:

Clinical Trial Credentialing: IROC Mission Clinical Trial Credentialing: Provide integrated radiation oncology and diagnostic Where imaging to Start quality and control programs in support of the NCI s NCTN Network thereby Resources

More information

MEDICAL UNIVERSITY of SOUTH CAROLINA

MEDICAL UNIVERSITY of SOUTH CAROLINA U. Joseph Schoepf, MD Prof. (h.c.), FAHA, FSCBT-MR, FNASCI, FSCCT Professor of Radiology, Medicine, and Pediatrics Director, Division of Cardiovascular Imaging MEDICAL UNIVERSITY of SOUTH CAROLINA Disclosures

More information